https://www.divatechnologies.com/wp-content/uploads/2021/07/Dublin_Launch.jpg

Diva Technologies brings AVID/Hx to Europe

14 Jul 2021
Share Article[Sassy_Social_Share]

FOR IMMEDIATE RELEASE:
14th July 2021

Diva Technologies is pleased to announce that it has released AVID/Hx in the European market.

Following the successful launch of AVID/Hx in the U.S. where a major pilot project is now underway, Diva Technologies today announces that it is being made available in Europe.

AVID/Hx, the innovative patient engagement and empowerment platform, has been enhanced to include functionality that allows family members or other trusted caregivers to have access to critical medications information for those who may need assistance and oversight to ensure their medication safety.

AVID/Hx allows for the safe recording of the patient’s medication regimen including drugs, dose, and frequency, and to automatically share this with a loved one or trusted caregiver near or far. Prior to a consultation, or in an emergency, this medication information can be quickly and easily sent to a Provider when having accurate, up-to-date medication is critical information for the safe management of the patient.

Commenting on this, Judy Gaughan, founder and Chief Executive Officer said: “This is a great step for Diva; every one of us wants our loved ones to be safe and now, with AVID/Hx, medication safety has just taken a huge leap forward.”
Gerard Bennett, co-founder and Chief Technology Officer said: “All development is carried out in Galway and, following our successful launch in the U.S. we’re delighted to bring AVID/Hx to Ireland and the wider European community. AVID/Hx has huge integration capabilities for all digital interfaces, and we look forward to working with partners here to leverage these strengths.”

ENDS.

Contacts:

USA: Judy Gaughan (judy.gaughan@divatechnologies.com) +1 978 502 7252

Ireland: T. Gerard Bennett (gerard.bennett@divatechnologies.com) + 353 87 979 2879

Download the app now!

Diva Technologies teams up with Massnex

11 Mar 2021
Share Article[Sassy_Social_Share]

Diva Technologies teams up with Massnex

Strategic partnership will expand Diva’s opportunity to take advantage of critical interest in how patient engagement can transform healthcare delivery.

Boston, MA March 11, 2021.

Diva Technologies announces that it has joined forces with Massnex, headed by Robert Schultz, to assist Diva in developing opportunities with major healthcare entities seeking innovative and effective patient engagement and patient empowerment technologies.

Diva, with its product, AVID/Hx, has created a powerful patient engagement platform that puts the patient at the center, and not only empowers the patient but creates a sense of accountability for the patient in the management of their own healthcare status.

AVID/Hx is an adaptable solution with very strong integration values and so making it ideal as a significant healthcare product in its own right but perfectly suited for integration with, or embodied in, other healthcare platforms that wish to leverage the functional strengths of AVID/Hx while at the same time as promoting the values of their own product.

According to Judy Gaughan, founder and Chief Executive Officer at Diva:

We’re delighted to be working with Rob and Yolanda, two people with enormous experience and credibility in this sector.  I’m happy that they share our vision of how AVID/Hx can transform patient engagement, making that engagement safer, while at the same time, doing this through a simple, intuitive, interface that the users holds in their own hands.  It is valuable to both the patient and Providers.

Rob Schultz, CEO at Massnex commented:

I met Judy a few months back and I was very impressed with her vision for this space.  Having looked in more detail at what Diva is doing, especially in the development of their software platform, AVID/Hx, I’m convinced that together, we can assist Diva to find its place in the strategic developments that are taking place today in digital healthcare.”

To learn more, go to our Contact Us page where you will find out how to get in touch.

Ends.